Open Access

The complex cascade of cellular events governing inflammasome activation and IL-1β processing in response to inhaled particles

Particle and Fibre Toxicology201613:40

https://doi.org/10.1186/s12989-016-0150-8

Received: 8 January 2016

Accepted: 12 July 2016

Published: 12 August 2016

Abstract

The innate immune system is the first line of defense against inhaled particles. Macrophages serve important roles in particle clearance and inflammatory reactions. Following recognition and internalization by phagocytes, particles are taken up in vesicular phagolysosomes. Intracellular phagosomal leakage, redox unbalance and ionic movements induced by toxic particles result in pro-IL-1β expression, inflammasome complex engagement, caspase-1 activation, pro-IL-1β cleavage, biologically-active IL-1β release and finally inflammatory cell death termed pyroptosis. In this review, we summarize the emerging signals and pathways involved in the expression, maturation and secretion of IL-1β during these responses to particles. We also highlight physicochemical characteristics of particles (size, surface and shape) which determine their capacity to induce inflammasome activation and IL-1β processing.

Keywords

Inflammasome Alarmins Cytokines Macrophages Silica Nanoparticles IL-1 family Inflammation

Background

Interleukin-1β (IL-1β) is a highly active cytokine playing an essential role in inflammation and tissue damage. An abundant literature has depicted the details of IL-1β regulation and functions during infectious and inflammatory diseases. Various IL-1β-targeting agents such as IL-1 receptor antagonist, soluble decoy receptor and neutralizing monoclonal anti-IL-1β antibody have been used with success in several inflammatory diseases such as rheumatisms, diabetes and cancers in humans [1, 2]. The different components of the IL-1β signaling pathway have been largely elucidated and comprise the IL-1 type 1 receptor (IL-1RI), its co-receptor (IL-1RAcP) and the adaptor molecule (MyD88). Research on IL-1β has recently been revitalized by the discovery of the inflammasome machinery (constituted of the caspase-1 enzyme, ASC adaptor and NLRP sensor) which allows the release of mature IL-1β from the immature and inactive IL-1β pro-form. The transcription of the IL1B gene encoding pro-IL1β results from the activation of the transcription factors nuclear factor-kB (NFkB) and activator protein 1 (AP-1) [3, 4].

Intense research on the IL-1β/inflammasome axis has resulted in new concepts of cell death pathways and related signaling cascades. Activated caspase-1 cleaves gasdermin D to induce a lytic cell death, termed pyroptosis [5]. Pyroptosis represents a necrotic cell death that induces cell swelling and plasma membrane rupture with release of mature IL-1β and cytoplasmic content leading to an inflammatory reaction. IL-1β processing is, however, not specifically related to necrosis. Apoptosis-related caspase-8 also binds to inflammasome complexes, activates the NLRP3 inflammasome and processes IL-1β to induce apoptotic cell death. Similarly, RIPK3- and MLKL-dependent necroptotic signaling can activate the NLRP3 inflammasome to drive IL-1β inflammatory responses [57]. These findings strongly support the intimate interrelation of IL-1β processing and cell death. Finally, IL-1β release can occur independently of caspase1/inflammasome pathway through cleavage mechanisms related to cathepsins [810].

Interestingly, very early research on IL-1β revealed that monocyte-derived macrophages or tissue macrophages exposed to silica or asbestos particles strongly release IL-1β. Particle-induced inflammasome activation, IL-1β release and pyroptosis are still mostly described in macrophages and the exact cellular mechanisms that result in IL-1β processing after exposure to cytotoxic doses of particles have been mainly discovered in macrophages. However, other immune cells such as dendritic cells or monocytes are also able to release large amount of mature IL-1β. In addition, structural cells of various body compartments exposed to particles secrete, although to a lesser extent, mature IL-1β [1118]. For instance, primary rat epithelial lung cells, cardiomyocytes, cardiofibroblasts and mesothelial cells also respond to particles by priming and activating inflammasome [13, 16, 1921]. It remains however to explore whether the mechanisms of inflammasome activation and IL-1β maturation in these cells correspond to those defined in macrophages.

A major role of mature IL-1β in asbestosis and silicosis was proposed more than 30 years ago [2224]. It is now well-established that active IL-1β serves as a primary initiating signal to coordinate the mobilization of immune cells to the damaged area caused by particles. Seminal studies in lung toxicology showed that IL-1β produced by particle-exposed macrophages induces, in concert with TNF-α, the production of chemokines by epithelial cells and mediates particle-induced neutrophil and macrophage influx and subsequent inflammatory lung responses [2527]. The exact in vivo role of IL-1β in the development of chronic inflammation, fibrosis and cancer induced by particles has been reviewed in recent publications [2831].

This review summarizes current knowledge on the main cellular signals responsible for the release of mature IL-1β after particle exposure. We first recapitulate the endogenous mediators (called signal 1) that prime the expression of the inactive pro-form of IL-1β (pro-IL-1β) by macrophages during the early response to particles. The second part delineates the intracellular events induced by particles (called signal 2) that result in NLRP3 inflammasome activation and IL-1β processing in macrophages. Finally, we highlight the physicochemical features of the particles which determine IL-1β processing.

Priming cells to express pro-IL-1β: the role of alarmins and inflammatory cytokines

Activation of the IL-1 pathway requires first signals which comprise priming molecules inducing the transcription of pro-IL-1β through the NFkB/AP-1 signal transduction axis (signal 1). A variety of danger signals, also called alarmins, have been recognized as the first inflammatory signal elements strongly inducing pro-IL-1β expression. These molecules are usually sequestered inside homeostatic cells but released in the extracellular environment when the cell membrane is corrupted during necrosis, pyroptosis or if apoptotic bodies are not rapidly cleared and release their cytoplasmic content (secondary necrosis) (reviewed in [32]). The cytokines IL-1α, IL-33 and HMGB1 as well as certain heat shock (HSP) or S100 proteins are considered as potent alarmins during inflammation or immune responses to pathogens. They bind membrane receptors and trigger inflammatory pathways leading to NFkB or AP-1 activation and pro-IL-1β gene transcription. Besides alarmins, it is well known that IL-1β itself and TNF-α, another master pro-inflammatory cytokine, which are rapidly released by macrophages after exposure to particles, are considered as crucial priming factors (see Fig. 1).
Fig. 1

Processes involved in particle-induced pro-IL-1β expression. Pro-IL-1β expression requires intermediary mediators (signal 1). Silica-damaged macrophages or structural cells release intracellular proteins called alarmins that possess inflammatory activities once present in the extracellular environment. HGMB1 (High mobility group box-1), S100 and HSP (Heat shock proteins) proteins bind to multi-ligand receptors such as RAGE (Receptor for advanced glycation endproducts) or TLRs (Toll-like receptors) and stimulate the NFkB (transcription factors nuclear factor-kB)/AP-1 (Activator protein 1) pathway, leading to pro-IL-1β expression by surrounding macrophages. IL-1α and IL-33, two members of the IL-1 family, also pass across damaged cell membranes and bind their specific receptors, IL-1RI and ST2 (Interleukin 1 receptor-like 1), respectively. Additionally, other cytokines that are not classified as alarmins but known to promote pro-IL-1β production via NFkB/AP-1 activation (i.e., TNF-α and IL-1β itself) also participate in the expression of pro-IL-1β and synergize with alarmins

  1. 1.

    Interleukin-1α

     

Expression of IL-1α is constitutive in diverse cells types in relation to the NFkB/AP-1 activation pathway (reviewed in [33, 34]). Akin IL-β, IL-1α is produced as a precursor. However, this pro-form is active and can bind IL-1RI to induce the production of inflammatory molecules. IL-1α lacks a secretory sequence signal and is released by an unconventional secretory pathway by simple diffusion across cell membrane upon membrane damage and necrosis or upon inflammasome activation. Several studies investigated IL-1α release in response to particles in LPS-primed cells [12, 3537]. Less well described is the release of constitutive IL-1α cellular content. Primary rat lung epithelial cells exposed to ultrafine carbon black released IL-1α independently of a concomitant gene expression. The release of IL-1α preceded and amplified the production of other pro-inflammatory molecules such as IL-6 [16].

Fine (PM2.5) and, to a lesser extent, coarse particulates (PM10) from urban atmosphere induced IL-1α release from human bronchial epithelial cell line (BEAS-2B) [38]. We observed that IL-1α was released from cellular stocks present in primary macrophages or a macrophage cell line after exposure to silica or carbon nanotubes (CNT). Importantly, IL-1β release and neutrophil recruitment in the lung response to silica instillation were strongly reduced when mice received IL-1α neutralizing antibodies or in IL-1α-deficient mice [39, 40]. Similarly, IL-1β release in the peritoneal cavity following monosodium urate (MSU) injection was reduced in IL-1α-deficient mice [35]. These findings strongly support the view that IL-1α represents a major early signal released after particle exposure that allows the expression of IL-1β.
  1. 2.

    HMGB1

     
HMGB1 is constitutively expressed in all cells and can be released following cell necrosis or secreted by activated immune cells. Extracellular HMGB1, alone or complexed to other pro-inflammatory molecules can bind the RAGE receptor or TLRs, trigger the NFkB and AP-1 pathway and induce pro-inflammatory cytokine production [41, 42]. Particle-induced HMGB1 release has been documented in human macrophages and bronchial epithelial cell lines treated with silica or in asbestos-exposed mesothelial cells [14, 20, 21]. Passive and active release of HMGB1 has also been reported in cultures of an epithelial cell line or primary alveolar macrophages exposed to MWCNT [43]. The presence of HMGB1 in the extracellular environment increased IL-1β secretion by MWCNT-treated alveolar macrophages. Interestingly, inhibition of extracellular HMGB1 by neutralizing antibodies reduced MWCNT-induced IL-1β secretion and inflammation in vivo [43]. By using RAGE-deficient mice, Ramsgaard and colleagues also demonstrated that this receptor is involved in neutrophil influx following silica lung exposure [44]. Thus, HMGB1 is an additional important alarmin that mediates the expression of IL-1β.
  1. 3.

    Interleukin-33

     
Interleukin-33, a cytokine of the interleukin-1 family, is expressed by structural and inflammatory cells and, as a pro-form or after maturation, activates its receptor ST2 [45]. Similar to interleukin-1α and β, the precursor of this interleukin can be matured upon cleavage by several enzymes with different effects on its activity. Cleavage by caspase-1, 7 or 8 inactivates IL-33 whereas calpain and neutrophil- or mastocyte-derived proteases have the opposite effect by enhancing the alarmin activity [46]. IL-33 release in response to particle exposure has been reported in several studies. Alum has been shown to induce IL-33 release from THP-1 macrophages [47] and MWCNT induced IL-33 release in supernatant of an epithelial cell line and in broncho-alveolar lavage fluid of mice [4851]. Although IL-33 is highly released after particle exposure, it is still unclear whether IL-33 is central to the induction of IL-1β expression after particle treatment.
  1. 4.

    Other alarmins implicated in particle-induced priming

     
S100A8/S100A9 proteins are constitutively expressed by phagocytes and released by non-classical pathways or by diffusion across cell membrane upon necrosis. Once in the extracellular environment, these mediators bind TLR4 or RAGE and activate the NFkB and AP-1 pathway (reviewed in [52, 53]). High levels of S100A8 and S100A9 were detected in BAL of rats exposed to diesel exhaust or ZnO particles [54, 55] and in lung tissue of mice exposed to SWCNT [56]. Heat shock protein (HSP) form a group of proteins that can bind various types of receptors, activate NFkB and trigger pro-inflammatory cytokine production ([57, 58] and reviewed in [59]). HSP60 release and subsequent TLR4 engagement have been implicated in the production of pro-IL-1β in monocytes exposed to polyethylene particles [60]. Despite their well-recognized role in sterile inflammation, S100 and HSP proteins have received little attention for their possible implication in IL-1β priming in the frame of particle-induced inflammation.
  1. 5.

    Other cytokines implicated in particle-induced priming

     

IL-1β regulates its own gene expression since its receptor IL-1RI is directly connected to the NFkB and AP-1 axis [61]. This suggests a possible autocrine loop in the production of pro-IL-1β during responses to particles. Interestingly, constitutive expression of pro-IL-1β has already been described in non-immune cells [14, 6264]. The maturation of this constitutive pro-IL-1β may result from intracellular inflammasome mobilization or external proteases after pro-IL-1β diffusion [6567]. Kono and colleagues observed that while IL-1β was crucial in silica-induced inflammatory response, caspase-1-deficient mice demonstrated only a limited reduction of inflammatory parameters in comparison to cathepsin C-deficient mice. Cathepsin C is necessary for activating serine proteases, and the authors postulated that its absence impaired extracellular IL-1β activation mediated by these proteases [8].

TNF-α is a powerful activator of NFkB/AP-1 and is known to induce IL-1β expression [68]. Under resting conditions, TNF-α translation is repressed in most cells [69] but rapidly restored under stress conditions [70]. In addition, a membrane-bound precursor of TNF-α can be processed by a TNF-α converting enzyme (TACE) to promptly generate secreted mature TNF-α [71]. Thus, TNF-α can be rapidly produced and released, independently of transcriptional induction, and can mediate early pro-IL-1β production. Release of TNF-α has been shown in response to different types of particles such as titanium nanoparticles, carbon nanotubes, polymethylmethacrylate particles, PM10 ambient particulate matter, wood smoke and traffic particles in vitro or in vivo [7277]. Inhibition of TNF-α by a neutralizing antibody has been shown to reduce IL-1β production by A549 cells and human bronchial epithelial cells exposed to urban PM10 [75]. Interestingly, TNF-α promotes caspase-1 activation in response to silica [78].

Thus even if they are not considered to be constitutively expressed and stored such as classical alarmins, early release of IL-1β and TNF-α are involved in the priming step that allows immune cells to produce high amounts of IL-1β.

Signals and mechanisms implicated in inflammasome processing of IL-1β in response to particles

The inflammasome is a multimeric complex mainly constituted by a sensor protein, the adapter protein Apoptosis-associated Speck-like protein containing CARD (ASC), and the cysteine protease caspase-1. Detection of a stimulus triggers a conformational change of sensor protein that leads to its oligomerization, recruitment of ASC through homotypic protein–protein interactions of the pyrin domains and subsequent recruitment and auto-activation of caspase-1, which in turn cleaves pro-IL-1β into its mature form [79]. NLPR3 is the sensor protein that has been mostly investigated in the context of particle-induced responses. NLRP3 is predominantly expressed in macrophages. NLRP3 inflammasome activation (also termed assembly or engagement) was first demonstrated by using MSU and calcium pyrophosphate dihydrate (CPPD) crystals [80]. Subsequently, a plethora of studies confirmed that diverse inflammatory particles are able to activate the NLRP3-inflammasome machinery. However, it appeared obvious that the NLRP3-protein complex cannot be directly triggered by particles themselves. Intensive investigations exploring indirect cellular events (signal 2) have led to propose at least four main processes accounting for inflammasome activation in response to particles: (1) lysosomal damage and subsequent lysosome content release, (2) modifications of intracellular ionic concentrations and localization, (3) intracellular redox unbalance and (4) organelle damage (summarized in Fig. 2).
Fig. 2

Cellular signals responsible for particle-induced inflammasome activation. Inflammasome activation after particle exposure results from various intracellular events (called signal 2) that are non-mutually exclusive. When endocytosed, nano- and micrometric-particles or exogenous NLRP3 complexes induce lysosomal destabilization and interfere with autophagy/mitophagy resulting in the release of ROS (Reactive oxygen species), cathepsins (Cat) or calcium in the cytosol. These vesicular leaking molecules promote the assembly of inflammasome components (NLRP3/ASC/Caspase-1) and subsequent IL-1β maturation from inactive pro-IL-1β form. Oxidative stress and active cathepsins modify undetermined protein structures which are recognized by the NLRP3 inflammasome. High calcium concentrations due to lysosomal but also endoplasmic reticulum release or extracellular influx via TRP (Transient receptor potential) calcium-channels affect mitochondria which release high amount of ROS. TAK1 (Tat-associated kinase), a kinase activated by increased intracellular calcium, is also implicated in inflammasome processing. Depletion in intracellular potassium is mandatory for inflammasome activation. Potassium cell efflux is indeed a necessary and sufficient signal for inflammasome activation and IL-1β processing. ATP release upon cell membrane damage permeates P2X7R (P2X purinoceptor 7) channels to potassium. Particle endocytosis is not systematically required and contact between cell membrane and particles resulting in the formation of lipid rafts is sufficient to trigger inflammasome engagement through SYK (Spleen tyrosine kinase) activation. The small size of nanoparticles allows them to cross biological membranes. Nanoparticles reach the cytosol even in absence of active endocytic process and may damage organelles such as mitochondria. Water movements through AQP (Aquaporin) 1 are necessary for inflammasome activation. Water channels are involved in inflammasome by regulating cytoskeleton rearrangement, ionic movements and TRP activation

  1. 1.

    Critical role of lysosomal damage

     

Endocytosis

The importance of endocytosis for particle-induced inflammasome engagement has been first demonstrated by using the actin polymerization inhibitors cytochalasin or lactrunculin in mononuclear and dendritic cells exposed to silica particles [8184]. The essential role of actin-mediated endocytosis was further robustly established in response to various particles such as aluminum salt-constituted [36, 81, 85, 86], titanium dioxide (TiO2) [87] or polymeric particles [36, 88, 89] and asbestos or CNT fiber-shaped particles [90, 91]. However, cellular uptake of particles is not an obligatory step for the processing and the secretion of IL-1β after particle exposure. Indeed, a direct contact between particles and the cell membrane can be sufficient for activating the inflammasome complex in macrophages or dendritic cells. Macrophages significantly released IL-1β even if they were exposed to non-phagocytozed polymethylmethacrylate microspheres or MSU crystals [92, 93]. In addition, cell contact of non-phagocytable polystyrene beads [36] or surface-glued alum crystals also resulted in IL-1β secretion by dendritic cells without internalization [94]. In comparison with internalized particles, cell membrane-associated silica highly induced IL-1β release by macrophages [95]. Finally, lipid raft formation at cell membrane surface also leads to IL-1β secretion in response to large polymeric particles [92].

Thus, it appears that particle recognition and/or endocytosis are competent to cause inflammasome and IL-1β processing.

Damage to lysosome

Lysosomal rupture, induced by soluble destabilizing agents such as L-leucyl-L-leucine methyl ester (Leu-Leu-OMe), is sufficient for inflammasome activation [84]. A clear correlation has also been found between the lysosomolytic ability of particles and inflammasome activation potency. Silica particles accountable for a robust lysosomal destabilization induced IL-1β secretion [82, 96]. Implication of lysosomal leakage in inflammasome mobilization is now demonstrated in response to diverse silica particles in macrophages [82, 83, 95, 97] or dendritic cells [36]. Interestingly, the in vitro membranolytic activity of silica particles on red blood cells predicts the labilization of the phagolysosome, the activation of inflammasome and release of IL-1β [98].

Particles are endocytosed in vesicular phagosomes which then undergo fusion with lysosomes, forming phagolysosomes. The fusion of particle-containing vesicles with lysosomes leads to acidification and ROS production in an attempt to digest particles. Both biological processes can be implicated in lysosomal destabilization and inflammasome activation. Indeed, inhibition of endosomal acidification by bafilomycin A1 successfully reduced lysosomal leakage and the subsequent IL-1β production in macrophages or dendritic cells exposed to silica, titanium, alum or polymeric particles [36, 8284, 87, 97]. Also, pretreatment of silica-exposed macrophages with the ROS scavenger butylated hydroxyanisole (BHA) strongly reduced endosomal rupture and subsequent IL-1β release [83].

Cytosolic leakage of cathepsin B after lysosomal damage also causes NLRP3 activation. The CA-074-Me cathepsin B inhibitor strongly affects IL-1β maturation induced by several fibrous and non-fibrous particles such as silica [35, 81, 83, 84, 97], titanium [12, 35, 87, 99], aluminum [36, 81, 85] or polymeric particles [36, 88], asbestos or CNT [37, 100]. However, the role of cathepsin B in particle-induced inflammasome activation is still a matter of debate. Indeed, cathepsin B-deficient bone marrow-derived macrophages (BMDMs) did not secrete less IL-1β and did not cleave caspase-1 less than WT cells in response to alum or silica [90, 93]. Similarly, cathepsin B deficiency did not reduce IL-1β release induced by liposomes in BMDM cultures whereas a cathepsin B inhibitor did [101]. This discrepancy could be explained by the lack of specificity of cathepsin inhibitors used in vitro or by the redundancy between cathepsins [102]. How cathepsin release could be implicated in caspase-1 and inflammasome activation is also not clear. Cathepsin B can directly process pro-caspase-1 [103] but a general intracellular protein degradation caused by cathepsin B release, that in turn induces caspase-1 activation, represents a more probable mechanism. In particular, cathepsin B leakage is also involved in mitochondrial damage [104] or potassium efflux [86], two processes that are mandatory in inflammasome activation (see below).

Finally, the lysosome contains high concentrations of ions and their release upon lysosomal membrane damage may also explain inflammasome activation. In particular, lysosomal damage and leakage can lead to deleterious cytosolic calcium concentrations and inflammasome activation [105].

In conclusion, particle-induced lysosomal damages induce multiple cellular perturbations that combine to maximize inflammasome activation in response to particles.

Autophagy

Lysosomal functions are not limited to digestion of endocytosed materials but also concern endogenous material elimination by a process called autophagy [106]. Autophagy is necessary to degrade and recycle damaged proteins and organelles, such as mitochondria. Inhibition of autophagy/mitophagy induces accumulation of ROS-generating damaged mitochondria and potentiates IL-1β processing in response to MSU crystals and soluble nigericin [107]. Particles impair normal autophagolysosome formation and induce inflammasome activation by the following events [106]. First, accumulation of non-destructible particles in phagolysosome leads to lysosome overload and prevents their fusion with autophagosomes [108]. Secondly, once in the cytosol, particles can bind to actin and impair cytoskeleton remodeling that is necessary for maturation and function of the autophagosome [109]. Finally, particles present in the cytosol can diffuse through the membrane and be incorporated in autophagic vesicles leading to their destabilization. For instance, nanoparticles can be incorporated to autophagic vesicles when ubiquitinated or associated with ubiquitinated proteins [110].

Altogether, these recent observations support the view that particles impair proper autophagic processes, favoring damaged mitochondria accumulation resulting in inflammasome processing.
  1. 2.

    Ionic modifications

     

Potassium

Reduced intracellular potassium concentration is mandatory for inflammasome activation. Reduction of intracellular potassium level induces a conformational change of NLRP3 allowing its activation [86, 111]. Additionally, potassium efflux could cause disruption of mitochondrial membrane potential [112] or ROS production [113]. Potassium efflux has been observed in response to silica exposure before IL-1β release and its inhibition reduced IL-1β and caspase-1 activation in response to silica, alum, silver or polymeric particles, asbestos or CNT in macrophages or dendritic cells [35, 36, 86, 89, 91, 101, 114117]. How particle exposure leads to potassium efflux is still unknown. It has been suggested that plasma membrane damages or distortions caused by particle contact with cell surface may explain cellular potassium leakage. Activation of the P2X7R cation-channel in response to ATP binding has also been implicated in particle-induced potassium efflux and inflammasome activation. Riteau and colleagues demonstrated that following silica or alum phagocytosis and subsequent lysosomal leakage, cellular ATP is released in the extracellular environment where it can bind to P2X7R and activate the inflammasome [118]. IL-1β release in response to latex beads was also reduced in presence of apyrase (ATP diphosphohydrolase) or in P2X7R-deficient macrophages [89]. However, the implication of ATP and P2X7R in potassium efflux in the context of inhaled particles remains controversial since silica-induced IL-1β release by macrophages was not reduced by apyrase nor deficiency in P2X7R in other studies [117, 119, 120]. Thus, the exact mechanism by which potassium is released by particle-exposed cells still needs to be determined. Adenosine released by particle-exposed macrophages also activates the NLRP3 inflammasome by interacting with adenosine receptors and through cellular uptake by nucleoside transporters [121].

Calcium

While potassium efflux is a necessary and sufficient signal, modification of free cytosolic calcium concentrations has also been implicated in inflammasome activation in response to soluble activators [105, 122]. Few studies have investigated calcium modifications in cells exposed to particles and the role of this ion in inflammasome activation remains uncertain. It has been shown that alum crystals induce calcium mobilization from the endoplasmic reticulum that is required for NLRP3 inflammasome activation in BMDM cells [105]. Extracellular calcium influx also affects intracellular calcium balance. Exposure to silica and alum increased free cytosolic calcium concentration by an extracellular entry through ROS-activated TRPM2 channel (Transient receptor potential cation channel, subfamily M, member 2). Reduction of this influx by lowering extracellular calcium or suppressing TRPM2 channels leads to a partial decrease of IL-1β secretion [101, 105]. Calcium is implicated in multiple cellular functions and probably impacts the particle-induced inflammasome activation process at different levels. Indeed, actin polymerization and organelle trafficking necessary for phagolysosomal maturation are dependent of intracellular calcium movements. Thus, increased concentration of calcium could impact particle uptake and subsequent lysosomal damage. Potassium efflux necessary for inflammasome activation is also triggered by the activation of calcium-dependent potassium channels when cytosolic calcium concentrations are increased [123]. Finally, high levels of cellular calcium also induce mitochondrial dysfunction or trigger activation of TGF-β-activated kinase 1 (TAK1), both associated with inflammasome activation [105, 111].

In conclusion, it is probable that alteration of intracellular calcium homeostasis is involved in particle-induced inflammasome mobilization. However, the elucidation of the mechanism leading to this ionic dysregulation needs future investigations in cells exposed to particles.
  1. 3.

    Oxidative stress

     

Increased cellular production of ROS has been observed in response to most inflammasome activators. Interestingly, silica-induced ROS production was detected even in NLRP3-deficient macrophages, indicating that ROS production is upstream of inflammasome activation [114]. The use of ROS scavengers such as N-acetylcysteine or ebselen, a glutathione peroxidase mimic, efficiently reduced IL-1β release and caspase-1 activation in response to particles such as silica, alum or asbestos in dendritic or mesothelial cells [19, 35] and the deficiency in the ROS detoxifying protein thioredoxin (TRX) increased IL-1β maturation induced by silica and asbestos in macrophage cell lines [115]. TRX overexpression or treatment with recombinant TRX attenuated caspase-1 enzymatic activity and secretion of IL-1β in silica-exposed epithelial cell or macrophage cultures [124]. These data convincingly demonstrate that ROS production is a crucial event in inflammasome processing in response to particles.

In addition to ROS produced intrinsically by the particles themselves, the NADPH oxidase pathway and the damaged mitochondria also lead to intracellular ROS production. Upon particle phagocytosis, phagosome-associated NADPH oxidase produces ROS that could be released in the cytosol upon lysosomal leakage. Inhibition of NADPH oxidase by ROS inhibitors such as diphenyleneiodonium (DPI), ammonium pyrrolidinedithiocarbamate (APDC) or apocynin reduced IL-1β secretion or caspase-1 activation in response to silica, asbestos, CNT or titanium particles [37, 83, 87, 90, 101, 114, 115, 125]. The use of mice deficient in essential components of the membrane-associated phagocyte NADPH oxidase led, however, to confusing results. Cells lacking the p22phox expression had reduced inflammasome activation in response to asbestos whereas deficiency in gp91phox did not modify silica-induced inflammasome activation [84, 90, 115]. Interestingly, mitochondrial ROS production during inflammasome activation has also been demonstrated after silica and alum treatment in macrophages [85, 125]. Altogether, these studies indicate that the enzymatic and cellular pathways leading to ROS-induced inflammasome activation are diverse and might depend on particle physicochemical properties.

How ROS activate NLRP3 is still debated but it is postulated that proteins modified by oxidative stress directly bind NLRP3. The complex formed by the ROS detoxifying protein thioredoxin (TRX) and thioredoxin-interacting protein (TXNIP) has also been proposed to link ROS and NLRP3 activation. Under normal conditions, TXNIP is associated with TRX. However, the presence of free radicals oxidizes TRX that cannot bind TXNIP anymore. TXNIP then interacts with and activates NLRP3. TXNIP deficiency in antigen-presenting cells reduced caspase-1 activation and IL-1β release induced by silica, asbestos and alum [19, 107, 115]. The absence of TXNIP has also been shown to prevent IL-1β release in a model of MSU-induced peritonitis [107]. However, two studies failed to confirm requirement of TXNIP for inflammasome activation in response to silica and latex beads in BMDM [89, 126]. Finally, there is evidence that the sources of ROS are multiple and interconnected. Indeed, ROS released by particles or phagolysosomes directly or indirectly activate mitochondria to produce ROS. This amplification loop of free radical generation may explain why anti-oxidant cell defenses are supplanted after particle exposure and that the subsequent oxidative stress generated in cells activates inflammasome machinery.
  1. 4.

    Organelle damage

     
Mitochondrial damage has been proposed as an important event in NLRP3 inflammasome activation in response to soluble activators [107, 125] and has been associated with particle-induced inflammasome activation [89, 95, 116, 127]. Cathepsins, ROS and calcium release after lysosomal leakage participate to the mitochondrial damage induced by particles [104, 128]. Additionally, particles present in the cytosol after diffusion or lysosomal escape may directly affect normal mitochondrial function which may result in inflammasome activation [116]. Inhibition of damaged mitochondria clearance in BMDM exposed to latex beads leads to increased IL-1β release, probably due to uncontrolled ROS release [89]. Under resting conditions NLRP3 localizes to endoplasmic reticulum (ER) structures in THP-1 macrophages but upon exposure to inflammasome-activating crystals such as alum, NLRP3/ER complexes and ASC are relocalized to mitochondria. Authors proposed that mitochondria recruit inflammasome components and favor their interactions. Additionally, voltage-dependent anion-selective channel protein 1 (VDAC1), a channel present at the mitochondrial membrane and controlling calcium transfer from ER, was implicated in caspase-1 activation and IL-1β release in response to silica and alum, possibly via ROS production [107]. Finally, cardiolipin, a mitochondrial-specific phospholipid, translocates from the inner to the outer mitochondrial membrane and binds NLRP3, explaining why inflammasome co-localizes with mitochondria. This interaction then leads to caspase-1-mediated IL-1β cleavage [125].
  1. 5.

    New mechanisms of particles-induced inflammasome activation

     

Macrophage swelling and subsequent regulatory volume decrease have been associated with NLRP3 inflammasome activation and IL-1β maturation in response to different stimuli [35, 111, 129]. Interestingly, cell volume modifications have been reported in the past in response to particle endocytosis [37, 130, 131]. Recently, we demonstrated that water movements through aquaporin (AQP), in particular AQP1, are necessary for inflammasome activation in response to particles in murine macrophages. AQP is implicated in swelling and shrinkage of the cell to restore its homeostatic volume [132]. Several mechanisms could explain the role of AQP in inflammasome mobilization. AQP mediates cytoskeleton rearrangement [133] necessary for particle endocytosis, intracellular vesicular trafficking and inflammasome components localization with filamentous actin [134136]. The reduction of AQP-controlled water flux and volume alterations probably affect potassium and calcium movements which are necessary for particle-induced inflammasome activation. AQP could be necessary for calcium-channel TRP activation [137, 138].

The ubiquitination process allows addressing protein to the proteasome for their elimination, and regulates inflammasome activity by targeting the degradation of inflammasome components by autophagy [139]. For instance, NLRP3 ubiquitination reduced inflammasome activation in response to various activators such as silica crystals [140]. On the other hand, it has been shown that the linear ubiquitination of ASC is necessary for silica-induced inflammasome activation in BMDM cells [141]. Ubiquitination may thus repress or promote the particle-induced inflammasome machinery according to the ubiquitinated protein and ubiquitination process considered.

Various kinases have been implicated in the pathway leading to IL-1β secretion after particle exposure [16, 35, 142, 143]. In particular, Spleen tyrosine kinase (SYK), a kinase regulating endocytosis and actin remodeling processes, has been involved in inflammasome activation in response to polymeric particles, silica, alum, asbestos and carbon nanotubes [37, 81, 92, 94]. In dendritic cells, contact between cell membrane and uric crystals results in membrane lipid alteration that induces activation of SYK and inflammasome activation [92, 94]. TAK1, a kinase involved in TLR signaling and activated by intracellular Ca2+ variations, has also been involved in inflammasome processing in response to ATP and osmotic stress [111, 144]. Interestingly, this kinase has also been involved in inflammasome processing consecutive to lysosomal rupture induced by Leu-Leu-OMe or uric crystals [145]. The GTPase effector Rho-kinases (ROCK1, and 2) regulating cytoskeleton and phagocytosis have also been involved in fibrous particle-induced inflammasome responses in THP-1 cells [146].

Recently, different groups demonstrated that inflammasome activation leads to the release of ASC and NLRP3 that form functional oligomeric inflammasome particles. These complexes can be subsequently phagocytized by surrounding macrophages and trigger lysosomal damage and inflammasome activation. Additionally, ASC-NLRP3 complexes also form functional inflammasomes in bystander macrophages after being internalized [147149].

Physicochemical characteristics of particles determining inflammasome activation

Contrary to water soluble agents, the toxicity of particles cannot solely be determined by chemical composition and molecular structure. Various characteristics such as (1) size, (2) surface curvature and (3) surface area or shape strongly affect particle internalization, intracellular localization, cell responses and IL-1β processing. A summary of studies considering the influence of particle characteristics on inflammasome activation and IL-1β release is provided in Tables 1, 2 and 3.
Table 1

Effects of particle size on the ability of cultured phagocytes to process and release IL-1β

Size

Chemical composition (doses)

Primary size (nm)

Hydrodynamic diameter (nm)

IL-1β release

Identified mechanisms

Cell type

Reference

Amorphous silica (100–1000 μg/ml)

20

295

++++

Lysosomal acidification and cathepsin B activity

Macrophages

[97]

67

91

+++

Lysosomal acidification and cathepsin B activity

  

369

531

++

N.a.

  

500 - 10000

342 - 5560

+

Lysosomal acidification and cathepsin B activity

  

30

/

++++

Actin-mediated endocytosis and lysosomal acidification

Macrophages

[82]

100

/

+++

Actin-mediated endocytosis and lysosomal acidification

  

300

/

+++

Actin-mediated endocytosis and lysosomal acidification

  

1000

/

+++

Actin-mediated endocytosis and lysosomal acidification

  

3000

/

++

Actin-mediated endocytosis and lysosomal acidification

  

10000

/

+/−

Lysosomal acidification

  

Carbon black (62–687 μg/ml)

53,7

235

++

N.a.

Monocytes

[165]

525

636

+

N.a.

  

14

/

++

N.a.

Monocytes

[166]

260

/

-

N.a.

  

Silver (0.15 – 0.9 μg/ml)

5

/

++

Potassium efflux and oxydative stress

Monocytes

[116]

28

/

+

Potassium efflux and oxydative stress

  

100

/

-

N.a.

  

Polystyrene (120 – 3000 μg/ml)

1000

/

++++

N.a.

Dendritic cells

[36]

430

/

+++

Actin-mediated endocytosis, lysosomal acidification cathepsin B activity and potassium efflux

  

10 000

/

++

N.a.

  

32 000

/

+

N.a.

  

The smallest and fiber- or needle-like particles are particularly active to induce IL-1β release. Surface area properties and reactivity also govern inflammasome/IL-1β activation. Physical or chemical treatments aiming to reduce surface reactivity can control inflammogenicity of particles

N.a. not assessed, N.r. not relevant

Table 2

Effects of particle surface on the ability of cultured phagocytes to process and release IL-1β

Surface

Chemical composition (doses)

Surface characteristics

Radicals produced at cell surface

IL-1β release

Identified mechanisms

Cell type

Reference

Amorphous silica (50–200 μg/ml)

Midly -

+

++

Actin-mediated endocytosis, lysosomal acidification and cathepsin B activity, oxidative stress

Macrophages

[83]

- (−COOH)

/

+

Actin-mediated endocytosis, lysosomal acidification and cathepsin B activity, oxidative stress

  

+ (−NH2)

/

-

N. r.

  

Silanol +++

+++

+++

N.a.

Macrophages

[95]

Silanol +++

++

++

Independent of entry and cathepsin B release

  

Silanol ++

+

+

N.a.

  

Silanol +

+

-

N.r.

  

Polystyrene (100 μg/ml)

+ (−NH2)

/

+

Oxidative stress

Macrophages

[127]

- (−COOH)

/

-

N.r.

  

/

/

-

N.r.

  

Aluminum oxyhydroxyde (500 μg/ml)

OH- +++++

++++

++++

Actin-mediated endocytosis, lysosomal acidification and cathepsin B activity, oxidative stress

Monocytes and macrophages

[85]

OH- ++++

+++

+++

Actin-mediated endocytosis and cathepsin B activity, oxidative stress

  

OH- ++++

++

++

Actin-mediated endocytosis and cathepsin B activity, oxidative stress

  

OH- ++

+

+

Actin-mediated endocytosis and cathepsin B activity, oxidative stress

  

OH- +

+

+/−

Oxidative stress (actin-mediated endocytosis and cathepsin B activity not convincing)

  

MWCNT (10–100 μg/ml)

Raw

/

+++

Lysosomal damage and cathepsin B activity

Macrophages

[100]

Purified (less Ni contamination)

/

++

Lysosomal damage and cathepsin B activity

  

- (−COOH)

/

+

Cathepsin B activity

  

The smallest and fiber- or needle-like particles are particularly active to induce IL-1β release. Surface area properties and reactivity also govern inflammasome/IL-1β activation. Physical or chemical treatments aiming to reduce surface reactivity can control inflammogenicity of particles

N.a. not assessed, N.r. not relevant

Table 3

Effects of particle shape on the ability of cultured phagocytes to process and release IL-1β

Shape

Chemical composition (doses)

Shape

Length/width (nm) (ratio)

IL-1β release

Identified mechanisms

Cell type

Reference

Titanium rutile (20–500 μg/ml)

Spicula

40/10 (4)

++

Actin-mediated endocytosis, lipid raft, lysosomal acidification and cathepsin B activity, oxidative stress

Macrophages

[87]

Spheric

30-40 (≈1)

+

Actin-mediated endocytosis, lipid raft, lysosomal acidification and cathepsin B activity, oxidative stress

  

Poly(ethylene oxide) (3–100 μg/ml)

Spherical with budding

N.r.

++

Actin-mediated endocytosis and cathepsin B activity

Macrophages

[88]

Spherical

N.r.

+

Actin-mediated endocytosis and Cathepsin B activity

  

Spherical

N.r.

-

N.r.

  

Gold (2–10 μg/ml)

Rod

40/10 (4)

+

N.a.

Macrophages

[164]

Spherical

40 (≈1)

-

N.a.

  

Cubic

40/40/40 (≈1)

-

N.a.

  

Carbon (2–100 μg/ml)

Needle-like MWCNT

13 000/>50(<260)

+

Cathepsin B activity, oxydative stress, src/syk pathway and P2X7R activity

Macrophages

[37]

Tangled MWCNT

10 000–50 000/8 – 15(667–6250)

-

N.r.

  

Short MWCNT

1000 - 10 000/0,5 - 20/(50–20000)

-

N.r.

  

Needle-like MWCNT

4150/150 (28)

+++

Actin-mediated endocytosis

Macrophages

[163]

Needle-like HTCFNW

7600/586 (13)

++

N.a.

  

Needle-like HTCFNW

1800/365 (5)

+

Actin-mediated endocytosis

  

The smallest and fiber- or needle-like particles are particularly active to induce IL-1β release. Surface area properties and reactivity also govern inflammasome/IL-1β activation. Physical or chemical treatments aiming to reduce surface reactivity can control inflammogenicity of particles

N.a. not assessed, N.r. not relevant

  1. 1.

    Size

     

Particle size is decisive for the processing and release of biologically-active IL-1β by phagocytic cells. This notion results from recent studies showing that nanoparticles possess a strong capacity to induce IL-1β release. BMDM exposed to amorphous silica nanoparticles with size ranging from 30 nm to 10 μm released more IL-1β in response to the smallest particles (30–1000 nm > 3 μm > 10 μm, when compared on a mass-based dose). Lysosomal damage and not internalization or actin polymerization explained these size-related differences [82]. Another study confirmed that, when compared on a mass-based dose, nanometric amorphous silica particles induced more IL-1β release by macrophages than their submicrometric counterparts (50 nm vs 500 nm) [97]. BMDM and primary glial cells exposed to similar mass doses of latex beads released more IL-1β in response to 20 nm than 1 μm size particles. In this study, inflammasome activation was attributed to lysosomal destabilization and cathepsin B release for 20 nm particles and to ROS production and mitochondrial damage for 1 μm particles. Additionally, inflammasome activation by the 20 nm particles was associated with their capacity to induce cellular damage and ATP release [89]. In dendritic cells, IL-1β release after polystyrene particle exposure (mass dose) was higher in response to 430 nm and 1 μm than to the 10 or 32 μm particles. In this model, small polystyrene particles were more efficiently internalized in comparison with larger particles [36]. Silver nanoparticles of 5, 28 and 100 nm were all internalized in monocytes but only 5 and 28 nm induced vesicular damage with ROS production and IL-1β release [116]. The relatively low capacity of micrometric particles to activate the inflammasome appears related with a lower endocytosis and lysosomal damage. It is also important to emphasize that the small size of nanoparticles allows them to reach intracellular compartments such as mitochondria [150] or to bind proteins such as actin [109]. Simple diffusion of nanomaterials across the cell membrane can be sufficient to activate inflammasome in keratinocytes [12].

Altogether, these data suggest that smallest particles are more potent, on a mass-based dose, to activate inflammasome in phagocytic cells.

There are, however, some reported exceptions: THP-1 cells failed to release IL-1β in response to amorphous silica particles below 1 μm [83] and spherical polystyrene particles of 7–8 μm induced inflammasome processing in macrophages whereas 0.5 and 1 μm did not [88]. Long fiber-shaped carbon, TiO2 or CeO2 nanoparticles induced more IL-1β release than shorter ones in macrophages [37, 151153]. Importantly, the impact of particle size differs according to the cell type considered and their endocytic capacities. In non-phagocytic cells such as keratinocytes, only nanoparticles but not micrometric particles are internalized and induce inflammasome activity [12, 107].

Additionally, aggregation or agglomeration state of particles (mainly nanoparticles) modifies particle diameter, curvature, density, endocytosis and thus subsequent inflammasome activation. Surface area available for particle reactivity can also be modified upon aggregation/agglomeration (see below). Unfortunately, no study formally and directly assessed the impact of aggregation on IL-1β release. However, aluminum nanoplates and polyhedron of different aggregate sizes (hydrodynamic diameter of 93 nm and 333 nm, respectively) but with similar primary size, specific surface area and surface reactivity induced similar level of inflammasome processing suggesting minor impact of aggregation [85]. Our group also demonstrated that aggregation in the nanorange did not modify the cytotoxic effect of silica nanoparticles in macrophages [154].
  1. 2.

    Surface area

     

On a mass basis, nanoparticles were frequently claimed to be more cytotoxic, but, once normalized by particle number or surface area, this difference was blunted [155, 156]. This issue has also been addressed in the frame of inflammasome activation. Expressed in mass concentration, 50 nm amorphous silica particles induced more IL-1β release than 500 nm in macrophages but when dose was expressed in total surface area this trend was reversed [97]. Similarly, differences in IL-1β levels released by BMDM in response to amorphous silica particles ranging from 30 to 1000 nm were dampened upon normalization by particle number and almost abolished once expressed in total surface area. However, in this study, particles over 1 μm of diameter were less internalized and macrophages released lower amounts of IL-1β after surface area normalization [82]. Altogether, these data suggest that surface area highly determines inflammasome activity of internalized particles.

Reactive groups present at particle surface can also affect the ability of particles to induce inflammasome activation. It is already known that silanol groups present on the surface of silica particles are associated with their toxic activity [157, 158]. Interestingly, reduction of silanol surface density by heating was associated with a decreased IL-1β secretion by THP-1 cells. Subsequent rehydration restored initial silanol concentration on particle surface together with IL-1β processing and release, demonstrating their implication in inflammasome activation. However, in the same study, particles with similar size, surface area and silanol characteristics but with different synthesis process presented different levels of inflammasome activation capacity, probably in relation with their ability to produce free radicals under acellular conditions [95]. The hydroxyl surface amount also affected IL-1β release in response to aluminum nanoparticles in THP-1 cultures. Indeed, particle presenting higher amounts of surface hydroxyl induced more inflammasome processing. This effect was attributed by the authors to an increased capacity of hydroxyl-rich particles to induce ROS production and lysosomal damage [85]. Surface metal contaminants can also exacerbate IL-1β cleavage by catalyzing surface radical production on particles. Chelation of iron reduced IL-1β maturation after asbestos exposure probably by limiting oxidative stress [115]. Oxidative dissolution of silver nanoparticles upon lysosomal acidification leads to Ag ion release, ROS byproducts, mitochondrial-derived ROS and ultimately inflammasome activation in THP-1 cells [159, 160]. Nickel contamination was also implicated in CNT-induced inflammasome activtion in mouse primary alveolar macrophages [161].

Importantly, functionalization of amorphous silica particles with various surface groups (−COOH, −NH2, −SO3H and -CHO) reduced particle-induced IL-1β release by THP-1 cells. These functionalizations reduced endosomal rupture, cathepsin B leakage and ROS production by limiting the access of surface silanol groups without affecting particle uptake [83]. Carboxylic functionalization of MWCNT completely inhibited IL-1β release by macrophages after clearing nickel contaminant [100, 151]. Carboxylation of titanium nanobelts also reduced IL-1β release by mouse alveolar macrophages and THP-1 cells, probably by reducing lysosomal damage [162].

Particle surface charge appears as another parameter important for inflammasome processing. Polystyrene beads induced lysosomal damage, cathepsin B release, mitochondrial ROS production and IL-1β release solely after amino-functionalization. Amino-functionalization induced lysosomal destabilization consistent with the proton sponge theory. The amine present at particle surface traps protons. Consequently, proton pump activity is increased and each proton that enters the lysosome is accompanied by one chloride ion and one water molecule. This influx of ions and water leads to lysosomal swelling and destabilization as well as IL-1β release [127].

In conclusion, the surface reactivity determines the ability of particles to induce lysosomal membrane destabilization and inflammasome activation. This effect results from the surface characteristics, chemical composition or contamination. Consequently, treatments altering particle surface reactivity by eliminating reactive groups or contaminants can be useful in order to reduce particle inflammogenicity.
  1. 3.

    Shape

     

By affecting internalization and lysosomal stability, the shape of particles is another important parameter which determines the activity of particles on the inflammasome machinery. In particular the high length/width ratio appears important in inflammasome activation by fibers. Inert in THP-1 cells, CeO2 nanocubes or nanorods activate the inflammasome when their length is increased. Indeed, these high length/width aspect ratio particles were able to destabilize lysosomal membrane leading to cathepsin B release and subsequent inflammasome activation [153]. Long TiO2 nanobelts induced more inflammasome activation than short nanobelts and nanospheres in alveolar macrophages. This activity was also linked to lysosomal destabilization and cathepsin B release [152]. Similarly, spiculated TiO2 particles induced stronger IL-1β release by macrophages than spherical nanoparticles with similar size [87]. Long well-dispersed carbon nanotubes as well as needle-like calcined fullerene nanowhiskers (HTCFNW) activate more intensively inflammasome than their shorter counterpart [163]. Similarly, needle-like carbon nanotubes are more active than spherical carbon black nanoparticles and shorter nanotubes [37]. Among spherical and rod-shaped gold nanoparticles in the same size range (20 and 40 nm diameter sphere and 10 nm witdh/40 nm length rods), only rods were able to induce IL-1β release, even if all were endocytosed and both 20 nm spheres and rods escaped lysosomes [164]. Curvature is also an important particle characteristic for inflammasome activation. Spherical polymeric particles composed of budding with combination of high positive and negative surface curvature released more IL-1β than smooth particles of the same size (7–8 μm). This effect was correlated with the level of internalized or associated budding particles [88].

Altogether, these data indicate that the shape of particles is also a major parameter determining particle-induced inflammasome activation. Particles with an aspect ratio close to one are particularly less efficient to induce inflammasome activation than the longer ones.

Conclusions

After particle exposure, alarmins retained intracellularly as preexisting stocks in lung resident cells and additional early pro-inflammatory cytokines are released into the extracellular milieu. These first inflammatory mediators (signal 1, Fig. 1) are potent activating stimuli required for macrophages, meso- and epithelial cells to express the biologically inactive precursor IL-1β (pro-IL-1β). This form is subsequently cleaved by particle-induced inflammasome activation prior its secretion as mature and bioactive IL-1β.

The processes leading to inflammasome activation and IL-1β maturation are initiated following lysosomal destabilization and leakage of enzymes, ions or ROS (signal 2, Fig. 2). These cellular events can result in mitochondrial damage, crucial to NLRP3 and inflammasome activation. Physicochemical characteristics of particles such as size and shape are decisive for particle internalization and lysosomal alteration. The smallest and fiber- or needle-like particles are particularly active to induce inflammasome activation. Surface area properties and reactivity also govern lysosomal damage and subsequent inflammasome/IL-1β processing. Physical or chemical treatments aiming to reduce surface reactivity can control inflammogenicity of particles. Nanoparticles can reach intracellular compartments and trigger metabolic processes, and induce toxicity and inflammasome activation by new pathways that are still to delineate. The observation that diverse particles are able to activate the inflammasome machinery allows considering the IL-1-related machinery as a new and crucial pathogenic pathway in particle toxicology.

Abbreviations

AM, alveolar macrophages; AP-1, activator protein 1; AQP, aquaporin 1; ASC, apoptosis-associated speck-like protein containing CARD; ATP, adenosine triphosphate; BMDM, bone marrow-derived macrophages; Casp-1, cysteine protease caspase-1; Cat, cathepsin; CB, carbon black; CeO2, cerium oxide; CNT, carbon nanotube; CPPD, calcium pyrophosphate dihydrate; HGMB1, high mobility group box-1; HSP, heat shock protein; IL, interleukin; LPS, lipopolysaccharides; MLKL, mixed lineage kinase domain-like; MSU, monosodium urate crystals; MW, multi walled; Myd88, myeloid differentiation primary response gene 88; NF-kB, nuclear factor-kappa B; NLR, NOD-like receptor or nucleotide-binding oligomerization domain receptor; NLRP3, NLR family pyrin domain contain 3; P2X7R, P2X purinoceptor 7; PM, particulate matter; RAGE, receptor for advanced glycation end products; RIPK3, receptor interacting serine/threonine kinase 3; ROS, reactive oxygen species; ST2, interleukin 1 receptor-like 1; SW, single walled; SYK, Spleen tyrosine kinase; TACE, TNF-α converting enzyme; TAK1, Tat-associated kinase or TGF-β-activated kinase 1; THP-1, human monocytic cell line; TiO2, titanium dioxide; TLRs, toll-like receptors; TNF, tumor necrosis factor; TRP, transient receptor potential; TRPM2, transient receptor potential cation channel, subfamily M, member 2; TRX, detoxifying protein thioredoxin; TXNIP, thioredoxin-interacting protein

Declarations

Acknowledgements

Not applicable.

Funding

This work was funded by the Fonds de la Recherche Scientifique Médicale (FRSM), by Actions de Recherche Concertées, Communauté française de Belgique, Direction de la Recherche Scientifique (ARC 09/14-021), by the Fondation Contre le Cancer, by the Fonds de la Recherche Scientifique (FNRS; Project PDR T.0119.13 14633768), by the European Commission under FP7-HEALTH-F4-2008 (Contract no. 202047). F.H. is a Research Associate with the FNRS, Belgium.

Availability of data and materials

Not applicable.

Authors’ contributions

VR drafted and designed the manuscript. DL and FH revised the manuscript. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

Not applicable.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Louvain Centre for Toxicology and Applied Pharmacology (LTAP), Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain

References

  1. Garlanda C, Dinarello CA, Mantovani A. The interleukin-1 family: back to the future. Immunity. 2013;39:1003–18.PubMedPubMed CentralView ArticleGoogle Scholar
  2. Dinarello CA, Simon A, van der Meer JW. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov. 2012;11:633–52.PubMedPubMed CentralView ArticleGoogle Scholar
  3. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002;10:417–26.PubMedView ArticleGoogle Scholar
  4. Lamkanfi M, Dixit VM. Mechanisms and functions of inflammasomes. Cell. 2014;157:1013–22.PubMedView ArticleGoogle Scholar
  5. Vince JE, Silke J. The intersection of cell death and inflammasome activation. Cell Mol Life Sci. 2016;73:2349–67.PubMedView ArticleGoogle Scholar
  6. de Vasconcelos NM, Van Opdenbosch N, Lamkanfi M. Inflammasomes as polyvalent cell death platforms. Cell Mol Life Sci. 2016;73:2335–47.PubMedView ArticleGoogle Scholar
  7. Moriwaki K, Chan FK. Necroptosis-independent signaling by the RIP kinases in inflammation. Cell Mol Life Sci. 2016;73:2325–34.PubMedView ArticleGoogle Scholar
  8. Kono H, Orlowski GM, Patel Z, Rock KL. The IL-1-dependent sterile inflammatory response has a substantial caspase-1-independent component that requires cathepsin C. J Immunol. 2012;189:3734–40.PubMedPubMed CentralView ArticleGoogle Scholar
  9. Hughes CS, Colhoun LM, Bains BK, Kilgour JD, Burden RE, Burrows JF, Lavelle EC, Gilmore BF, Scott CJ. Extracellular cathepsin S and intracellular caspase 1 activation are surrogate biomarkers of particulate-induced lysosomal disruption in macrophages. Part Fibre Toxicol. 2016;13:19.PubMedPubMed CentralView ArticleGoogle Scholar
  10. Provoost S, Maes T, Pauwels NS, Vanden Berghe T, Vandenabeele P, Lambrecht BN, Joos GF, Tournoy KG. NLRP3/caspase-1-independent IL-1beta production mediates diesel exhaust particle-induced pulmonary inflammation. J Immunol. 2011;187:3331–7.PubMedView ArticleGoogle Scholar
  11. Hiroike M, Sakabe J, Kobayashi M, Shimauchi T, Ito T, Hirakawa S, Inoh A, Tokura Y. Acicular, but not globular, titanium dioxide nanoparticles stimulate keratinocytes to produce pro-inflammatory cytokines. J Dermatol. 2013;40:357–62.PubMedView ArticleGoogle Scholar
  12. Yazdi AS, Guarda G, Riteau N, Drexler SK, Tardivel A, Couillin I, Tschopp J. Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1alpha and IL-1beta. Proc Natl Acad Sci U S A. 2010;107:19449–54.PubMedPubMed CentralView ArticleGoogle Scholar
  13. Totlandsdal AI, Refsnes M, Skomedal T, Osnes JB, Schwarze PE, Lag M. Particle-induced cytokine responses in cardiac cell cultures--the effect of particles versus soluble mediators released by particle-exposed lung cells. Toxicol Sci. 2008;106:233–41.PubMedView ArticleGoogle Scholar
  14. Peeters PM, Perkins TN, Wouters EF, Mossman BT, Reynaert NL. Silica induces NLRP3 inflammasome activation in human lung epithelial cells. Part Fibre Toxicol. 2013;10:3.PubMedPubMed CentralView ArticleGoogle Scholar
  15. Hussain S, Sangtian S, Anderson SM, Snyder RJ, Marshburn JD, Rice AB, Bonner JC, Garantziotis S. Inflammasome activation in airway epithelial cells after multi-walled carbon nanotube exposure mediates a profibrotic response in lung fibroblasts. Part Fibre Toxicol. 2014;11:28.PubMedPubMed CentralView ArticleGoogle Scholar
  16. Totlandsdal AI, Refsnes M, Lag M. Mechanisms involved in ultrafine carbon black-induced release of IL-6 from primary rat epithelial lung cells. Toxicol In Vitro. 2010;24:10–20.PubMedView ArticleGoogle Scholar
  17. Fujii T, Hayashi S, Hogg JC, Vincent R, Van Eeden SF. Particulate matter induces cytokine expression in human bronchial epithelial cells. Am J Respir Cell Mol Biol. 2001;25:265–71.PubMedView ArticleGoogle Scholar
  18. Hirota JA, Hirota SA, Warner SM, Stefanowicz D, Shaheen F, Beck PL, Macdonald JA, Hackett TL, Sin DD, Van Eeden S, Knight DA. The airway epithelium nucleotide-binding domain and leucine-rich repeat protein 3 inflammasome is activated by urban particulate matter. J Allergy Clin Immunol. 2012;129:1116–25. e1116.PubMedView ArticleGoogle Scholar
  19. Thompson JK, Westbom CM, MacPherson MB, Mossman BT, Heintz NH, Spiess P, Shukla A. Asbestos modulates thioredoxin-thioredoxin interacting protein interaction to regulate inflammasome activation. Part Fibre Toxicol. 2014;11:24.PubMedPubMed CentralView ArticleGoogle Scholar
  20. Hillegass JM, Miller JM, MacPherson MB, Westbom CM, Sayan M, Thompson JK, Macura SL, Perkins TN, Beuschel SL, Alexeeva V, et al. Asbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cells. Part Fibre Toxicol. 2013;10:39.PubMedPubMed CentralView ArticleGoogle Scholar
  21. Yang H, Rivera Z, Jube S, Nasu M, Bertino P, Goparaju C, Franzoso G, Lotze MT, Krausz T, Pass HI, et al. Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Proc Natl Acad Sci U S A. 2010;107:12611–6.PubMedPubMed CentralView ArticleGoogle Scholar
  22. Oghiso Y, Kubota Y. Interleukin 1 production and accessory cell function of rat alveolar macrophages exposed to mineral dust particles. Microbiol Immunol. 1987;31:275–87.PubMedView ArticleGoogle Scholar
  23. Pernis B, Vigliani EC. The role of macrophages and immunocytes in the pathogenesis of pulmonary diseases due to mineral dusts. Am J Ind Med. 1982;3:133–7.PubMedView ArticleGoogle Scholar
  24. Lepe-Zuniga JL, Gery I. Production of intra- and extracellular interleukin-1 (IL-1) by human monocytes. Clin Immunol Immunopathol. 1984;31:222–30.PubMedView ArticleGoogle Scholar
  25. Driscoll KE, Lindenschmidt RC, Maurer JK, Higgins JM, Ridder G. Pulmonary response to silica or titanium dioxide: inflammatory cells, alveolar macrophage-derived cytokines, and histopathology. Am J Respir Cell Mol Biol. 1990;2:381–90.PubMedView ArticleGoogle Scholar
  26. Pryhuber GS, Huyck HL, Baggs R, Oberdorster G, Finkelstein JN. Induction of chemokines by low-dose intratracheal silica is reduced in TNFR I (p55) null mice. Toxicol Sci. 2003;72:150–7.PubMedPubMed CentralView ArticleGoogle Scholar
  27. Piguet PF, Collart MA, Grau GE, Sappino AP, Vassalli P. Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature. 1990;344:245–7.PubMedView ArticleGoogle Scholar
  28. Rastrick J, Birrell M. The role of the inflammasome in fibrotic respiratory diseases. Minerva Med. 2014;105:9–23.PubMedGoogle Scholar
  29. Mills KH, Dungan LS, Jones SA, Harris J. The role of inflammasome-derived IL-1 in driving IL-17 responses. J Leukoc Biol. 2013;93:489–97.PubMedView ArticleGoogle Scholar
  30. Pollard KM. Silica, Silicosis, and Autoimmunity. Front Immunol. 2016;7:97.PubMedPubMed CentralView ArticleGoogle Scholar
  31. Leung CC, Yu IT, Chen W. Silicosis. Lancet. 2012;379:2008–18.View ArticlePubMedGoogle Scholar
  32. Zitvogel L, Kepp O, Kroemer G. Decoding cell death signals in inflammation and immunity. Cell. 2010;140:798–804.PubMedView ArticleGoogle Scholar
  33. Rider P, Carmi Y, Guttman O, Braiman A, Cohen I, Voronov E, White MR, Dinarello CA, Apte RN. IL-1alpha and IL-1beta recruit different myeloid cells and promote different stages of sterile inflammation. J Immunol. 2011;187:4835–43.PubMedView ArticleGoogle Scholar
  34. Dinarello CA, van der Meer JW. Treating inflammation by blocking interleukin-1 in humans. Semin Immunol. 2013;25:469–84.PubMedPubMed CentralView ArticleGoogle Scholar
  35. Gross O, Yazdi AS, Thomas CJ, Masin M, Heinz LX, Guarda G, Quadroni M, Drexler SK, Tschopp J. Inflammasome activators induce interleukin-1alpha secretion via distinct pathways with differential requirement for the protease function of caspase-1. Immunity. 2012;36:388–400.PubMedView ArticleGoogle Scholar
  36. Sharp FA, Ruane D, Claass B, Creagh E, Harris J, Malyala P, Singh M, O'Hagan DT, Petrilli V, Tschopp J, et al. Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc Natl Acad Sci U S A. 2009;106:870–5.PubMedPubMed CentralView ArticleGoogle Scholar
  37. Palomaki J, Valimaki E, Sund J, Vippola M, Clausen PA, Jensen KA, Savolainen K, Matikainen S, Alenius H. Long, needle-like carbon nanotubes and asbestos activate the NLRP3 inflammasome through a similar mechanism. ACS Nano. 2011;5:6861–70.PubMedView ArticleGoogle Scholar
  38. Watterson TL, Hamilton B, Martin RS, Coulombe Jr RA. Urban particulate matter activates Akt in human lung cells. Arch Toxicol. 2012;86:121–35.PubMedView ArticleGoogle Scholar
  39. Rabolli V, Badissi A, Devosse R, Uwambayinema F, Yakoub Y, Palmai-Pallag M, Lebrun A, De Gussem V, Couillin I, Ryffel B, et al. The alarmin IL-1 inverted question mark is a master cytokine in acute lung inflammation induced by silica micro- and nanoparticles. Part Fibre Toxicol. 2014;11:69.PubMedPubMed CentralView ArticleGoogle Scholar
  40. Huaux F, Lo Re S, Giordano G, Uwambayinema F, Devosse R, Yakoub Y, Panin N, Palmai-Pallag M, Rabolli V, Delos M, et al. IL-1alpha induces CD11b alveolar macrophage proliferation and maturation during granuloma formation. J Pathol. 2014.Google Scholar
  41. Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R, Zhang M, Yang H, Tracey KJ. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med. 2000;192:565–70.PubMedPubMed CentralView ArticleGoogle Scholar
  42. Yang H, Hreggvidsdottir HS, Palmblad K, Wang H, Ochani M, Li J, Lu B, Chavan S, Rosas-Ballina M, Al-Abed Y, et al. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci U S A. 2010;107:11942–7.PubMedPubMed CentralView ArticleGoogle Scholar
  43. Jessop F, Holian A. Extracellular HMGB1 regulates multi-walled carbon nanotube-induced inflammation in vivo. Nanotoxicology. 2014;1–8.Google Scholar
  44. Ramsgaard L, Englert JM, Tobolewski J, Tomai L, Fattman CL, Leme AS, Kaynar AM, Shapiro SD, Enghild JJ, Oury TD. The role of the receptor for advanced glycation end-products in a murine model of silicosis. PLoS One. 2010;5:e9604.PubMedPubMed CentralView ArticleGoogle Scholar
  45. Carriere V, Roussel L, Ortega N, Lacorre DA, Americh L, Aguilar L, Bouche G, Girard JP. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci U S A. 2007;104:282–7.PubMedView ArticleGoogle Scholar
  46. Lefrancais E, Roga S, Gautier V, Gonzalez-de-Peredo A, Monsarrat B, Girard JP, Cayrol C. IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc Natl Acad Sci U S A. 2012;109:1673–8.PubMedPubMed CentralView ArticleGoogle Scholar
  47. Li H, Willingham SB, Ting JP, Re F. Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J Immunol. 2008;181:17–21.PubMedPubMed CentralView ArticleGoogle Scholar
  48. Sager TM, Wolfarth MW, Andrew M, Hubbs A, Friend S, Chen TH, Porter DW, Wu N, Yang F, Hamilton RF, Holian A. Effect of multi-walled carbon nanotube surface modification on bioactivity in the C57BL/6 mouse model. Nanotoxicology. 2014;8:317–27.PubMedView ArticleGoogle Scholar
  49. Beamer CA, Girtsman TA, Seaver BP, Finsaas KJ, Migliaccio CT, Perry VK, Rottman JB, Smith DE, Holian A. IL-33 mediates multi-walled carbon nanotube (MWCNT)-induced airway hyper-reactivity via the mobilization of innate helper cells in the lung. Nanotoxicology. 2013;7:1070–81.PubMedView ArticleGoogle Scholar
  50. Wang X, Katwa P, Podila R, Chen P, Ke PC, Rao AM, Walters DM, Wingard CJ, Brown JM. Multi-walled carbon nanotube instillation impairs pulmonary function in C57BL/6 mice. Part Fibre Toxicol. 2011;8:24.PubMedPubMed CentralView ArticleGoogle Scholar
  51. Katwa P, Wang X, Urankar RN, Podila R, Hilderbrand SC, Fick RB, Rao AM, Ke PC, Wingard CJ, Brown JM. A carbon nanotube toxicity paradigm driven by mast cells and the IL-(3)(3)/ST(2) axis. Small. 2012;8:2904–12.PubMedPubMed CentralView ArticleGoogle Scholar
  52. Kessel C, Holzinger D, Foell D. Phagocyte-derived S100 proteins in autoinflammation: putative role in pathogenesis and usefulness as biomarkers. Clin Immunol. 2013;147:229–41.PubMedView ArticleGoogle Scholar
  53. Goyette J, Geczy CL. Inflammation-associated S100 proteins: new mechanisms that regulate function. Amino Acids. 2011;41:821–42.PubMedView ArticleGoogle Scholar
  54. Lewis JA, Rao KM, Castranova V, Vallyathan V, Dennis WE, Knechtges PL. Proteomic analysis of bronchoalveolar lavage fluid: effect of acute exposure to diesel exhaust particles in rats. Environ Health Perspect. 2007;115:756–63.PubMedPubMed CentralView ArticleGoogle Scholar
  55. Juang YM, Lai BH, Chien HJ, Ho M, Cheng TJ, Lai CC. Changes in protein expression in rat bronchoalveolar lavage fluid after exposure to zinc oxide nanoparticles: an iTRAQ proteomic approach. Rapid Commun Mass Spectrom. 2014;28:974–80.PubMedView ArticleGoogle Scholar
  56. Teeguarden JG, Webb-Robertson BJ, Waters KM, Murray AR, Kisin ER, Varnum SM, Jacobs JM, Pounds JG, Zanger RC, Shvedova AA. Comparative proteomics and pulmonary toxicity of instilled single-walled carbon nanotubes, crocidolite asbestos, and ultrafine carbon black in mice. Toxicol Sci. 2011;120:123–35.PubMedView ArticleGoogle Scholar
  57. Chen W, Syldath U, Bellmann K, Burkart V, Kolb H. Human 60-kDa heat-shock protein: a danger signal to the innate immune system. J Immunol. 1999;162:3212–9.PubMedGoogle Scholar
  58. Asea A, Kraeft SK, Kurt-Jones EA, Stevenson MA, Chen LB, Finberg RW, Koo GC, Calderwood SK. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med. 2000;6:435–42.PubMedView ArticleGoogle Scholar
  59. Tsan MF, Gao B. Heat shock proteins and immune system. J Leukoc Biol. 2009;85:905–10.View ArticlePubMedGoogle Scholar
  60. Hao HN, Zheng B, Nasser S, Ren W, Latteier M, Wooley P, Morawa L. The roles of monocytic heat shock protein 60 and Toll-like receptors in the regional inflammation response to wear debris particles. J Biomed Mater Res A. 2010;92:1373–81.PubMedGoogle Scholar
  61. Hiscott J, Marois J, Garoufalis J, D'Addario M, Roulston A, Kwan I, Pepin N, Lacoste J, Nguyen H, Bensi G, et al. Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop. Mol Cell Biol. 1993;13:6231–40.PubMedPubMed CentralView ArticleGoogle Scholar
  62. Blasi F, Riccio M, Brogi A, Strazza M, Taddei ML, Romagnoli S, Luddi A, D'Angelo R, Santi S, Costantino-Ceccarini E, Melli M. Constitutive expression of interleukin-1beta (IL-1beta) in rat oligodendrocytes. Biol Chem. 1999;380:259–64.PubMedView ArticleGoogle Scholar
  63. Marionnet AV, Chardonnet Y, Viac J, Schmitt D. Differences in responses of interleukin-1 and tumor necrosis factor alpha production and secretion to cyclosporin-A and ultraviolet B-irradiation by normal and transformed keratinocyte cultures. Exp Dermatol. 1997;6:22–8.PubMedView ArticleGoogle Scholar
  64. Tesch GH, Yang N, Yu H, Lan HY, Foti R, Chadban SJ, Atkins RC, Nikolic-Paterson DJ. Intrinsic renal cells are the major source of interleukin-1 beta synthesis in normal and diseased rat kidney. Nephrol Dial Transplant. 1997;12:1109–15.PubMedView ArticleGoogle Scholar
  65. Mizutani H, Schechter N, Lazarus G, Black RA, Kupper TS. Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase. J Exp Med. 1991;174:821–5.View ArticlePubMedGoogle Scholar
  66. Schonbeck U, Mach F, Libby P. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J Immunol. 1998;161:3340–6.PubMedGoogle Scholar
  67. Coeshott C, Ohnemus C, Pilyavskaya A, Ross S, Wieczorek M, Kroona H, Leimer AH, Cheronis J. Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. Proc Natl Acad Sci U S A. 1999;96:6261–6.PubMedPubMed CentralView ArticleGoogle Scholar
  68. Marucha PT, Zeff RA, Kreutzer DL. Cytokine regulation of IL-1 beta gene expression in the human polymorphonuclear leukocyte. J Immunol. 1990;145:2932–7.PubMedGoogle Scholar
  69. Han J, Brown T, Beutler B. Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J Exp Med. 1990;171:465–75.PubMedView ArticleGoogle Scholar
  70. Swantek JL, Cobb MH, Geppert TD. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK. Mol Cell Biol. 1997;17:6274–82.PubMedPubMed CentralView ArticleGoogle Scholar
  71. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature. 1997;385:729–33.PubMedView ArticleGoogle Scholar
  72. Zhang LW, Zeng L, Barron AR, Monteiro-Riviere NA. Biological interactions of functionalized single-wall carbon nanotubes in human epidermal keratinocytes. Int J Toxicol. 2007;26:103–13.PubMedView ArticleGoogle Scholar
  73. Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, Potapovich AI, Tyurina YY, Gorelik O, Arepalli S, Schwegler-Berry D, et al. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol. 2005;289:L698–708.PubMedView ArticleGoogle Scholar
  74. Ainslie KM, Tao SL, Popat KC, Daniels H, Hardev V, Grimes CA, Desai TA. In vitro inflammatory response of nanostructured titania, silicon oxide, and polycaprolactone. J Biomed Mater Res A. 2009;91:647–55.PubMedView ArticleGoogle Scholar
  75. Ishii H, Fujii T, Hogg JC, Hayashi S, Mukae H, Vincent R, van Eeden SF. Contribution of IL-1 beta and TNF-alpha to the initiation of the peripheral lung response to atmospheric particulates (PM10). Am J Physiol Lung Cell Mol Physiol. 2004;287:L176–83.PubMedView ArticleGoogle Scholar
  76. Kocbach A, Herseth JI, Lag M, Refsnes M, Schwarze PE. Particles from wood smoke and traffic induce differential pro-inflammatory response patterns in co-cultures. Toxicol Appl Pharmacol. 2008;232:317–26.PubMedView ArticleGoogle Scholar
  77. Pearl JI, Ma T, Irani AR, Huang Z, Robinson WH, Smith RL, Goodman SB. Role of the Toll-like receptor pathway in the recognition of orthopedic implant wear-debris particles. Biomaterials. 2011;32:5535–42.PubMedPubMed CentralView ArticleGoogle Scholar
  78. Franchi L, Eigenbrod T, Nunez G. Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J Immunol. 2009;183:792–6.PubMedPubMed CentralView ArticleGoogle Scholar
  79. Schroder K, Tschopp J. The inflammasomes. Cell. 2010;140:821–32.PubMedView ArticleGoogle Scholar
  80. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440:237–41.PubMedView ArticleGoogle Scholar
  81. Kuroda E, Ishii KJ, Uematsu S, Ohata K, Coban C, Akira S, Aritake K, Urade Y, Morimoto Y. Silica crystals and aluminum salts regulate the production of prostaglandin in macrophages via NALP3 inflammasome-independent mechanisms. Immunity. 2011;34:514–26.PubMedView ArticleGoogle Scholar
  82. Kusaka T, Nakayama M, Nakamura K, Ishimiya M, Furusawa E, Ogasawara K. Effect of silica particle size on macrophage inflammatory responses. PLoS One. 2014;9, e92634.PubMedPubMed CentralView ArticleGoogle Scholar
  83. Morishige T, Yoshioka Y, Inakura H, Tanabe A, Yao X, Narimatsu S, Monobe Y, Imazawa T, Tsunoda S, Tsutsumi Y, et al. The effect of surface modification of amorphous silica particles on NLRP3 inflammasome mediated IL-1beta production, ROS production and endosomal rupture. Biomaterials. 2010;31:6833–42.PubMedView ArticleGoogle Scholar
  84. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, Fitzgerald KA, Latz E. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol. 2008;9:847–56.PubMedPubMed CentralView ArticleGoogle Scholar
  85. Sun B, Ji Z, Liao YP, Wang M, Wang X, Dong J, Chang CH, Li R, Zhang H, Nel AE, Xia T. Engineering an effective immune adjuvant by designed control of shape and crystallinity of aluminum oxyhydroxide nanoparticles. ACS Nano. 2013;7:10834–49.PubMedPubMed CentralView ArticleGoogle Scholar
  86. Munoz-Planillo R, Kuffa P, Martinez-Colon G, Smith BL, Rajendiran TM, Nunez G. K(+) efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity. 2013;38:1142–53.PubMedPubMed CentralView ArticleGoogle Scholar
  87. Morishige T, Yoshioka Y, Tanabe A, Yao X, Tsunoda S, Tsutsumi Y, Mukai Y, Okada N, Nakagawa S. Titanium dioxide induces different levels of IL-1beta production dependent on its particle characteristics through caspase-1 activation mediated by reactive oxygen species and cathepsin B. Biochem Biophys Res Commun. 2010;392:160–5.PubMedView ArticleGoogle Scholar
  88. Vaine CA, Patel MK, Zhu J, Lee E, Finberg RW, Hayward RC, Kurt-Jones EA. Tuning innate immune activation by surface texturing of polymer microparticles: the role of shape in inflammasome activation. J Immunol. 2013;190:3525–32.PubMedPubMed CentralView ArticleGoogle Scholar
  89. Adachi T, Takahara K, Taneo J, Uchiyama Y, Inaba K. Particle size of latex beads dictates IL-1beta production mechanism. PLoS One. 2013;8, e68499.PubMedPubMed CentralView ArticleGoogle Scholar
  90. Dostert C, Guarda G, Romero JF, Menu P, Gross O, Tardivel A, Suva ML, Stehle JC, Kopf M, Stamenkovic I, et al. Malarial hemozoin is a Nalp3 inflammasome activating danger signal. PLoS One. 2009;4, e6510.PubMedPubMed CentralView ArticleGoogle Scholar
  91. Meunier E, Coste A, Olagnier D, Authier H, Lefevre L, Dardenne C, Bernad J, Beraud M, Flahaut E, Pipy B. Double-walled carbon nanotubes trigger IL-1beta release in human monocytes through Nlrp3 inflammasome activation. Nanomedicine. 2012;8:987–95.PubMedGoogle Scholar
  92. Malik AF, Hoque R, Ouyang X, Ghani A, Hong E, Khan K, Moore LB, Ng G, Munro F, Flavell RA, et al. Inflammasome components Asc and caspase-1 mediate biomaterial-induced inflammation and foreign body response. Proc Natl Acad Sci U S A. 2011;108:20095–100.PubMedPubMed CentralView ArticleGoogle Scholar
  93. Hari A, Zhang Y, Tu Z, Detampel P, Stenner M, Ganguly A, Shi Y. Activation of NLRP3 inflammasome by crystalline structures via cell surface contact. Sci Rep. 2014;4:7281.PubMedPubMed CentralView ArticleGoogle Scholar
  94. Flach TL, Ng G, Hari A, Desrosiers MD, Zhang P, Ward SM, Seamone ME, Vilaysane A, Mucsi AD, Fong Y, et al. Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity. Nat Med. 2011;17:479–87.PubMedView ArticleGoogle Scholar
  95. Zhang H, Dunphy DR, Jiang X, Meng H, Sun B, Tarn D, Xue M, Wang X, Lin S, Ji Z, et al. Processing pathway dependence of amorphous silica nanoparticle toxicity: colloidal vs pyrolytic. J Am Chem Soc. 2012;134:15790–804.PubMedPubMed CentralView ArticleGoogle Scholar
  96. Davis MJ, Swanson JA. Technical advance: Caspase-1 activation and IL-1beta release correlate with the degree of lysosome damage, as illustrated by a novel imaging method to quantify phagolysosome damage. J Leukoc Biol. 2010;88:813–22.PubMedPubMed CentralView ArticleGoogle Scholar
  97. Sandberg WJ, Lag M, Holme JA, Friede B, Gualtieri M, Kruszewski M, Schwarze PE, Skuland T, Refsnes M. Comparison of non-crystalline silica nanoparticles in IL-1beta release from macrophages. Part Fibre Toxicol. 2012;9:32.PubMedPubMed CentralView ArticleGoogle Scholar
  98. Pavan C, Rabolli V, Tomatis M, Fubini B, Lison D. Why does the hemolytic activity of silica predict its pro-inflammatory activity? Part Fibre Toxicol. 2014;11:76.PubMedPubMed CentralView ArticleGoogle Scholar
  99. St Pierre CA, Chan M, Iwakura Y, Ayers DC, Kurt-Jones EA, Finberg RW. Periprosthetic osteolysis: characterizing the innate immune response to titanium wear-particles. J Orthop Res. 2010;28:1418–24.PubMedPubMed CentralView ArticleGoogle Scholar
  100. Hamilton Jr RF, Xiang C, Li M, Ka I, Yang F, Ma D, Porter DW, Wu N, Holian A. Purification and sidewall functionalization of multiwalled carbon nanotubes and resulting bioactivity in two macrophage models. Inhal Toxicol. 2013;25:199–210.PubMedPubMed CentralView ArticleGoogle Scholar
  101. Zhong Z, Zhai Y, Liang S, Mori Y, Han R, Sutterwala FS, Qiao L. TRPM2 links oxidative stress to NLRP3 inflammasome activation. Nat Commun. 2013;4:1611.PubMedPubMed CentralView ArticleGoogle Scholar
  102. Orlowski GM, Colbert JD, Sharma S, Bogyo M, Robertson SA, Rock KL. Multiple Cathepsins Promote Pro-IL-1beta Synthesis and NLRP3-Mediated IL-1beta Activation. J Immunol. 2015;195:1685–97.PubMedView ArticleGoogle Scholar
  103. Vancompernolle K, Van Herreweghe F, Pynaert G, Van de Craen M, De Vos K, Totty N, Sterling A, Fiers W, Vandenabeele P, Grooten J. Atractyloside-induced release of cathepsin B, a protease with caspase-processing activity. FEBS Lett. 1998;438:150–8.PubMedView ArticleGoogle Scholar
  104. Guicciardi ME, Leist M, Gores GJ. Lysosomes in cell death. Oncogene. 2004;23:2881–90.PubMedView ArticleGoogle Scholar
  105. Murakami T, Ockinger J, Yu J, Byles V, McColl A, Hofer AM, Horng T. Critical role for calcium mobilization in activation of the NLRP3 inflammasome. Proc Natl Acad Sci U S A. 2012;109:11282–7.PubMedPubMed CentralView ArticleGoogle Scholar
  106. Stern ST, Adiseshaiah PP, Crist RM. Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity. Part Fibre Toxicol. 2012;9:20.PubMedPubMed CentralView ArticleGoogle Scholar
  107. Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature. 2011;469:221–5.PubMedView ArticleGoogle Scholar
  108. Wan B, Wang ZX, Lv QY, Dong PX, Zhao LX, Yang Y, Guo LH. Single-walled carbon nanotubes and graphene oxides induce autophagosome accumulation and lysosome impairment in primarily cultured murine peritoneal macrophages. Toxicol Lett. 2013;221:118–27.PubMedView ArticleGoogle Scholar
  109. Ehrenberg M, McGrath JL. Binding between particles and proteins in extracts: implications for microrheology and toxicity. Acta Biomater. 2005;1:305–15.PubMedView ArticleGoogle Scholar
  110. Calzolai L, Franchini F, Gilliland D, Rossi F. Protein--nanoparticle interaction: identification of the ubiquitin--gold nanoparticle interaction site. Nano Lett. 2010;10:3101–5.PubMedView ArticleGoogle Scholar
  111. Compan V, Baroja-Mazo A, Lopez-Castejon G, Gomez AI, Martinez CM, Angosto D, Montero MT, Herranz AS, Bazan E, Reimers D, et al. Cell volume regulation modulates NLRP3 inflammasome activation. Immunity. 2012;37:487–500.PubMedView ArticleGoogle Scholar
  112. El Kebir D, Jozsef L, Khreiss T, Filep JG. Inhibition of K+ efflux prevents mitochondrial dysfunction, and suppresses caspase-3-, apoptosis-inducing factor-, and endonuclease G-mediated constitutive apoptosis in human neutrophils. Cell Signal. 2006;18:2302–13.PubMedView ArticleGoogle Scholar
  113. Fay AJ, Qian X, Jan YN, Jan LY. SK channels mediate NADPH oxidase-independent reactive oxygen species production and apoptosis in granulocytes. Proc Natl Acad Sci U S A. 2006;103:17548–53.PubMedPubMed CentralView ArticleGoogle Scholar
  114. Cassel SL, Eisenbarth SC, Iyer SS, Sadler JJ, Colegio OR, Tephly LA, Carter AB, Rothman PB, Flavell RA, Sutterwala FS. The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci U S A. 2008;105:9035–40.PubMedPubMed CentralView ArticleGoogle Scholar
  115. Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science. 2008;320:674–7.PubMedPubMed CentralView ArticleGoogle Scholar
  116. Yang EJ, Kim S, Kim JS, Choi IH. Inflammasome formation and IL-1beta release by human blood monocytes in response to silver nanoparticles. Biomaterials. 2012;33:6858–67.PubMedView ArticleGoogle Scholar
  117. Eisenbarth SC, Colegio OR, O'Connor W, Sutterwala FS, Flavell RA. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature. 2008;453:1122–6.PubMedPubMed CentralView ArticleGoogle Scholar
  118. Riteau N, Baron L, Villeret B, Guillou N, Savigny F, Ryffel B, Rassendren F, Le Bert M, Gombault A, Couillin I. ATP release and purinergic signaling: a common pathway for particle-mediated inflammasome activation. Cell Death Dis. 2012;3, e403.PubMedPubMed CentralView ArticleGoogle Scholar
  119. Shimada K, Crother TR, Karlin J, Dagvadorj J, Chiba N, Chen S, Ramanujan VK, Wolf AJ, Vergnes L, Ojcius DM, et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity. 2012;36:401–14.PubMedPubMed CentralView ArticleGoogle Scholar
  120. Iyer SS, Pulskens WP, Sadler JJ, Butter LM, Teske GJ, Ulland TK, Eisenbarth SC, Florquin S, Flavell RA, Leemans JC, Sutterwala FS. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci U S A. 2009;106:20388–93.PubMedPubMed CentralView ArticleGoogle Scholar
  121. Baron L, Gombault A, Fanny M, Villeret B, Savigny F, Guillou N, Panek C, Le Bert M, Lagente V, Rassendren F, et al. The NLRP3 inflammasome is activated by nanoparticles through ATP. ADP and adenosine Cell Death Dis. 2015;6, e1629.PubMedView ArticleGoogle Scholar
  122. Lee GS, Subramanian N, Kim AI, Aksentijevich I, Goldbach-Mansky R, Sacks DB, Germain RN, Kastner DL, Chae JJ. The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP. Nature. 2012;492:123–7.PubMedPubMed CentralView ArticleGoogle Scholar
  123. Cahalan MD, Chandy KG. Ion channels in the immune system as targets for immunosuppression. Curr Opin Biotechnol. 1997;8:749–56.PubMedView ArticleGoogle Scholar
  124. Peeters PM, Eurlings IM, Perkins TN, Wouters EF, Schins RP, Borm PJ, Drommer W, Reynaert NL, Albrecht C. Silica-induced NLRP3 inflammasome activation in vitro and in rat lungs. Part Fibre Toxicol. 2014;11:58.PubMedPubMed CentralView ArticleGoogle Scholar
  125. Iyer SS, He Q, Janczy JR, Elliott EI, Zhong Z, Olivier AK, Sadler JJ, Knepper-Adrian V, Han R, Qiao L, et al. Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. Immunity. 2013;39:311–23.PubMedPubMed CentralView ArticleGoogle Scholar
  126. Masters SL, Dunne A, Subramanian SL, Hull RL, Tannahill GM, Sharp FA, Becker C, Franchi L, Yoshihara E, Chen Z, et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Nat Immunol. 2010;11:897–904.PubMedPubMed CentralView ArticleGoogle Scholar
  127. Lunov O, Syrovets T, Loos C, Nienhaus GU, Mailander V, Landfester K, Rouis M, Simmet T. Amino-functionalized polystyrene nanoparticles activate the NLRP3 inflammasome in human macrophages. ACS Nano. 2011;5:9648–57.PubMedView ArticleGoogle Scholar
  128. Zhao M, Antunes F, Eaton JW, Brunk UT. Lysosomal enzymes promote mitochondrial oxidant production, cytochrome c release and apoptosis. Eur J Biochem. 2003;270:3778–86.PubMedView ArticleGoogle Scholar
  129. Perregaux DG, Laliberte RE, Gabel CA. Human monocyte interleukin-1beta posttranslational processing. Evidence of a volume-regulated response. J Biol Chem. 1996;271:29830–8.PubMedView ArticleGoogle Scholar
  130. Reisetter AC, Stebounova LV, Baltrusaitis J, Powers L, Gupta A, Grassian VH, Monick MM. Induction of inflammasome-dependent pyroptosis by carbon black nanoparticles. J Biol Chem. 2011;286:21844–52.PubMedPubMed CentralView ArticleGoogle Scholar
  131. Morrow PE. Possible mechanisms to explain dust overloading of the lungs. Fundam Appl Toxicol. 1988;10:369–84.PubMedView ArticleGoogle Scholar
  132. Rabolli V, Wallemme L, Lo Re S, Uwambayinema F, Palmai-Pallag M, Thomassen L, Tyteca D, Octave JN, Marbaix E, Lison D, et al. Critical role of aquaporins in interleukin 1beta (IL-1beta)-induced inflammation. J Biol Chem. 2014;289:13937–47.PubMedPubMed CentralView ArticleGoogle Scholar
  133. Papadopoulos MC, Saadoun S, Verkman AS. Aquaporins and cell migration. Pflugers Arch. 2008;456:693–700.PubMedView ArticleGoogle Scholar
  134. Pelegrin P, Surprenant A. Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1beta release through pyrophosphates. EMBO J. 2009;28:2114–27.PubMedPubMed CentralView ArticleGoogle Scholar
  135. Mansfield E, Chae JJ, Komarow HD, Brotz TM, Frucht DM, Aksentijevich I, Kastner DL. The familial Mediterranean fever protein, pyrin, associates with microtubules and colocalizes with actin filaments. Blood. 2001;98:851–9.PubMedView ArticleGoogle Scholar
  136. Waite AL, Schaner P, Hu C, Richards N, Balci-Peynircioglu B, Hong A, Fox M, Gumucio DL. Pyrin and ASC co-localize to cellular sites that are rich in polymerizing actin. Exp Biol Med (Maywood). 2009;234:40–52.View ArticleGoogle Scholar
  137. Li L, Zhang H, Verkman AS. Greatly attenuated experimental autoimmune encephalomyelitis in aquaporin-4 knockout mice. BMC Neurosci. 2009;10:94.PubMedPubMed CentralView ArticleGoogle Scholar
  138. Nishihara E, Hiyama TY, Noda M. Osmosensitivity of transient receptor potential vanilloid 1 is synergistically enhanced by distinct activating stimuli such as temperature and protons. PLoS One. 2011;6, e22246.PubMedPubMed CentralView ArticleGoogle Scholar
  139. Shi CS, Shenderov K, Huang NN, Kabat J, Abu-Asab M, Fitzgerald KA, Sher A, Kehrl JH. Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol. 2012;13:255–63.PubMedPubMed CentralView ArticleGoogle Scholar
  140. Py BF, Kim MS, Vakifahmetoglu-Norberg H, Yuan J. Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity. Mol Cell. 2013;49:331–8.PubMedView ArticleGoogle Scholar
  141. Rodgers MA, Bowman JW, Fujita H, Orazio N, Shi M, Liang Q, Amatya R, Kelly TJ, Iwai K, Ting J, Jung JU. The linear ubiquitin assembly complex (LUBAC) is essential for NLRP3 inflammasome activation. J Exp Med. 2014;211:1333–47.PubMedPubMed CentralView ArticleGoogle Scholar
  142. Hara H, Tsuchiya K, Kawamura I, Fang R, Hernandez-Cuellar E, Shen Y, Mizuguchi J, Schweighoffer E, Tybulewicz V, Mitsuyama M. Phosphorylation of the adaptor ASC acts as a molecular switch that controls the formation of speck-like aggregates and inflammasome activity. Nat Immunol. 2013;14:1247–55.PubMedView ArticlePubMed CentralGoogle Scholar
  143. Lu B, Nakamura T, Inouye K, Li J, Tang Y, Lundback P, Valdes-Ferrer SI, Olofsson PS, Kalb T, Roth J, et al. Novel role of PKR in inflammasome activation and HMGB1 release. Nature. 2012;488:670–4.PubMedPubMed CentralView ArticleGoogle Scholar
  144. Gong YN, Wang X, Wang J, Yang Z, Li S, Yang J, Liu L, Lei X, Shao F. Chemical probing reveals insights into the signaling mechanism of inflammasome activation. Cell Res. 2010;20:1289–305.PubMedView ArticleGoogle Scholar
  145. Okada M, Matsuzawa A, Yoshimura A, Ichijo H. Lysosome rupture-activated TAK1-JNK pathway regulates NLRP3 inflammasome activation. J Biol Chem. 2014.Google Scholar
  146. Kanno S, Hirano S, Chiba S, Takeshita H, Nagai T, Takada M, Sakamoto K, Mukai T. The role of Rho-kinases in IL-1beta release through phagocytosis of fibrous particles in human monocytes. Arch Toxicol. 2014.Google Scholar
  147. Franklin BS, Bossaller L, De Nardo D, Ratter JM, Stutz A, Engels G, Brenker C, Nordhoff M, Mirandola SR, Al-Amoudi A, et al. The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation. Nat Immunol. 2014;15:727–37.PubMedPubMed CentralView ArticleGoogle Scholar
  148. Baroja-Mazo A, Martin-Sanchez F, Gomez AI, Martinez CM, Amores-Iniesta J, Compan V, Barbera-Cremades M, Yague J, Ruiz-Ortiz E, Anton J, et al. The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response. Nat Immunol. 2014;15:738–48.PubMedView ArticleGoogle Scholar
  149. de Almeida L, Khare S, Misharin AV, Patel R, Ratsimandresy RA, Wallin MC, Perlman H, Greaves DR, Hoffman HM, Dorfleutner A, Stehlik C. The PYRIN Domain-only Protein POP1 Inhibits Inflammasome Assembly and Ameliorates Inflammatory Disease. Immunity. 2015;43:264–76.PubMedView ArticleGoogle Scholar
  150. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006;311:622–7.PubMedView ArticleGoogle Scholar
  151. Hamilton Jr RF, Wu Z, Mitra S, Shaw PK, Holian A. Effect of MWCNT size, carboxylation, and purification on in vitro and in vivo toxicity, inflammation and lung pathology. Part Fibre Toxicol. 2013;10:57.PubMedPubMed CentralView ArticleGoogle Scholar
  152. Hamilton RF, Wu N, Porter D, Buford M, Wolfarth M, Holian A. Particle length-dependent titanium dioxide nanomaterials toxicity and bioactivity. Part Fibre Toxicol. 2009;6:35.PubMedPubMed CentralView ArticleGoogle Scholar
  153. Ji Z, Wang X, Zhang H, Lin S, Meng H, Sun B, George S, Xia T, Nel AE, Zink JI. Designed synthesis of CeO2 nanorods and nanowires for studying toxicological effects of high aspect ratio nanomaterials. ACS Nano. 2012;6:5366–80.PubMedPubMed CentralView ArticleGoogle Scholar
  154. Rabolli V, Thomassen LC, Uwambayinema F, Martens JA, Lison D. The cytotoxic activity of amorphous silica nanoparticles is mainly influenced by surface area and not by aggregation. Toxicol Lett. 2011;206:197–203.PubMedView ArticleGoogle Scholar
  155. Warheit DB, Webb TR, Colvin VL, Reed KL, Sayes CM. Pulmonary bioassay studies with nanoscale and fine-quartz particles in rats: toxicity is not dependent upon particle size but on surface characteristics. Toxicol Sci. 2007;95:270–80.PubMedView ArticleGoogle Scholar
  156. Rabolli V, Thomassen LC, Princen C, Napierska D, Gonzalez L, Kirsch-Volders M, Hoet PH, Huaux F, Kirschhock CE, Martens JA, Lison D. Influence of size, surface area and microporosity on the in vitro cytotoxic activity of amorphous silica nanoparticles in different cell types. Nanotoxicology. 2010;4:307–18.PubMedView ArticleGoogle Scholar
  157. Pavan C, Tomatis M, Ghiazza M, Rabolli V, Bolis V, Lison D, Fubini B. In search of the chemical basis of the hemolytic potential of silicas. Chem Res Toxicol. 2013;26:1188–98.PubMedView ArticleGoogle Scholar
  158. Fubini B, Zanetti G, Altilia S, Tiozzo R, Lison D, Saffiotti U. Relationship between surface properties and cellular responses to crystalline silica: studies with heat-treated cristobalite. Chem Res Toxicol. 1999;12:737–45.PubMedView ArticleGoogle Scholar
  159. Hamilton RF, Buckingham S, Holian A. The effect of size on Ag nanosphere toxicity in macrophage cell models and lung epithelial cell lines is dependent on particle dissolution. Int J Mol Sci. 2014;15:6815–30.PubMedPubMed CentralView ArticleGoogle Scholar
  160. Setyawati MI, Yuan X, Xie J, Leong DT. The influence of lysosomal stability of silver nanomaterials on their toxicity to human cells. Biomaterials. 2014;35:6707–15.PubMedView ArticleGoogle Scholar
  161. Hamilton Jr RF, Buford M, Xiang C, Wu N, Holian A. NLRP3 inflammasome activation in murine alveolar macrophages and related lung pathology is associated with MWCNT nickel contamination. Inhal Toxicol. 2012;24:995–1008.PubMedPubMed CentralView ArticleGoogle Scholar
  162. Hamilton RF, Wu N, Xiang C, Li M, Yang F, Wolfarth M, Porter DW, Holian A. Synthesis, characterization, and bioactivity of carboxylic acid-functionalized titanium dioxide nanobelts. Part Fibre Toxicol. 2014;11:43.PubMedPubMed CentralView ArticleGoogle Scholar
  163. Cui H, Wu W, Okuhira K, Miyazawa K, Hattori T, Sai K, Naito M, Suzuki K, Nishimura T, Sakamoto Y, et al. High-temperature calcined fullerene nanowhiskers as well as long needle-like multi-wall carbon nanotubes have abilities to induce NLRP3-mediated IL-1beta secretion. Biochem Biophys Res Commun. 2014.Google Scholar
  164. Niikura K, Matsunaga T, Suzuki T, Kobayashi S, Yamaguchi H, Orba Y, Kawaguchi A, Hasegawa H, Kajino K, Ninomiya T, et al. Gold nanoparticles as a vaccine platform: influence of size and shape on immunological responses in vitro and in vivo. ACS Nano. 2013;7:3926–38.PubMedView ArticleGoogle Scholar
  165. Sahu D, Kannan GM, Vijayaraghavan R. Carbon black particle exhibits size dependent toxicity in human monocytes. Int J Inflam. 2014;2014:827019.PubMedPubMed CentralView ArticleGoogle Scholar
  166. Brown DM, Donaldson K, Stone V. Nuclear translocation of Nrf2 and expression of antioxidant defence genes in THP-1 cells exposed to carbon nanotubes. J Biomed Nanotechnol. 2010;6:224–33.PubMedView ArticleGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement